NCT03496545View on ClinicalTrials.gov

Efficacy of Bromocriptine For Fever Reduction in Acute Neurologic Injury

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

November 30, 2018

Primary Completion Date

November 2, 2019

Study Completion Date

November 2, 2019

Conditions
Subarachnoid HemorrhageSubdural HematomaTraumatic Brain InjuryIschemic StrokeFeverIntracerebral Hemorrhage
Interventions
DRUG

Bromocriptine 5 MG

Bromocriptine 5 mg every 4 hours PO/NG/FT

DRUG

Acetaminophen 650 MG

Acetaminophen 650 mg every 4 hours PO/NG/FT for 48 hours

Trial Locations (2)

94110

Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco

94143

University of California, San Francisco Medical Center - Parnassus, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT03496545 - Efficacy of Bromocriptine For Fever Reduction in Acute Neurologic Injury | Biotech Hunter | Biotech Hunter